EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Inherited thrombocytopenia associated with a variant in the FLI1 binding site in the 5′ UTR of ANKRD26

Caitlin Dunstan-Harrison iD, Ian M Morison iD, Elizabeth C Ledgerwood iD

Clinical Genetics · 2024

DOI: 10.1111/cge.14547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2024. Verfasst von Caitlin Dunstan-Harrison und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Thrombocytopenia, 5' Untranslated Regions, Proto-Oncogene Protein c-fli-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lottery Health Research, Dean's Bequest Fund, University of Otago.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants in the 5′ UTR of ANKRD26 are a common cause of inherited thrombocytopenia ( ANKRD26 ‐RT), and are associated with sustained ANKRD26 expression, which inhibits megakaryocyte maturation and proplatelet formation. ANKRD26 expression is controlled by the binding of a RUNX1/FLI1 complex to the 5′ UTR. To date, all reported ANKRD26 ‐RD associated variants have been within the RUNX1 binding site and a 22 base pair flanking region. Here, we report a novel variant in the 5′ UTR of ANKRD26 , c.‐107C>T. This variant is in the FLI1 binding site, and is predicted to disrupt FLI1 binding due to loss of a hydrogen bond with FLI1. Differentiated PBMCs from affected family members showed impaired megakaryocyte maturation and proplatelet formation and sustained expression of ANKRD26 , and platelets from affected family members had higher ANKRD26 expression than control platelets. The variant increased activity of the ANKRD26 promotor in a reporter assay. We also provide evidence that the previously reported c.‐140C>G ANKRD26 5′ UTR variant is benign and not associated with thrombocytopenia. Identification of the c.‐107C>T variant extends the range of the regulatory region in the 5′ UTR of ANKRD26 that is associated with ANKRD26 ‐RT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thrombocytopenia5' Untranslated RegionsProto-Oncogene Protein c-fli-1HumansBinding SitesMaleFemalePedigreeMegakaryocytesBlood PlateletsCore Binding Factor Alpha 2 SubunitProtein BindingGenetic Predisposition to DiseaseIntercellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

ANKRD26FLI1RUNX1thrombocytopenia

Substanzen

ANKRD26 protein, human5' Untranslated RegionsProto-Oncogene Protein c-fli-1FLI1 protein, humanCore Binding Factor Alpha 2 SubunitIntercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
  • Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

ORCID-Profile: Caitlin Dunstan-Harrison, Ian M Morison, Elizabeth C Ledgerwood

Förderung

  • Lottery Health Research
  • Dean's Bequest Fund, University of Otago

Zitieren

APA

Dunstan-Harrison, C., Morison, I. M., & Ledgerwood, E. C. (2024). Inherited thrombocytopenia associated with a variant in the FLI1 binding site in the 5′ UTR of ANKRD26. Clinical Genetics. https://doi.org/10.1111/cge.14547

Vancouver

Dunstan-Harrison C, Morison IM, Ledgerwood EC. Inherited thrombocytopenia associated with a variant in the FLI1 binding site in the 5′ UTR of ANKRD26. Clinical Genetics. 2024. doi:10.1111/cge.14547

BibTeX
@article{DunstanHarrison2024,
  author = {Dunstan-Harrison, Caitlin and Morison, Ian M and Ledgerwood, Elizabeth C},
  title = {Inherited thrombocytopenia associated with a variant in the FLI1 binding site in the 5′ UTR of ANKRD26},
  journal = {Clinical Genetics},
  year = {2024},
  doi = {10.1111/cge.14547}
}
Kostenlos starten →